Response varies widely across individuals, with some losing over 25% body weight while others see minimal change
doi:10.1007/s11845-023-03602-4 Lacombe V, Vinatier E, Roquin G, et al
By mimicking the action of GLP-1, semaglutide can help regulate blood sugar levels in people with type 2 diabetes, suppress appetite and improve metabolism to aid in weight loss
In the SURMOUNT trials, tirzepatide at 15 mg averaged 22.5 percent body weight loss over 72 weeks, while the 5 mg and 10 mg doses landed roughly in the 15 to 20 percent range
Major trends: Growth of 'longevity' and 'healthspan' as consumer priorities, Increased use of glutathione in integrative and functional medicine, Rise of personalized supplementation based on biomarker testing, and Integration with other anti-aging and mitochondrial support ingredients